Stuart Gallagher

4.1k total citations · 2 hit papers
51 papers, 3.2k citations indexed

About

Stuart Gallagher is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Stuart Gallagher has authored 51 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 23 papers in Oncology and 11 papers in Immunology. Recurrent topics in Stuart Gallagher's work include Histone Deacetylase Inhibitors Research (14 papers), Melanoma and MAPK Pathways (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Stuart Gallagher is often cited by papers focused on Histone Deacetylase Inhibitors Research (14 papers), Melanoma and MAPK Pathways (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Stuart Gallagher collaborates with scholars based in Australia, United States and France. Stuart Gallagher's co-authors include Mark A. Creager, S. M. Coleman, John P. Cooke, Peter Hersey, Jessamy Tiffen, J Loscalzo, Victor J. Dzau, M E Mendelsohn, V J Dzau and Xavier Girerd and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Stuart Gallagher

50 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

1990 849 citations Mark A. Creager, John P. Cooke et al. Journal of Clinical Investigation profile →
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.

1992 670 citations Mark A. Creager, Stuart Gallagher et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart Gallagher Australia	26	1.3k	942	875	688	517	51	3.2k
Gerald D. Frank United States	33	1.6k 1.3×	914 1.0×	610 0.7×	329 0.5×	338 0.7×	43	2.8k
Makoto Usui Japan	27	1.0k 0.8×	1.4k 1.5×	828 0.9×	338 0.5×	543 1.1×	51	3.3k
Maren Luchtefeld Germany	20	652 0.5×	592 0.6×	400 0.5×	372 0.5×	822 1.6×	33	2.4k
Shanthi Adimoolam United States	14	964 0.8×	705 0.7×	914 1.0×	447 0.6×	127 0.2×	19	2.3k
Han Si United States	21	1.4k 1.1×	401 0.4×	513 0.6×	449 0.7×	196 0.4×	55	2.7k
Yuqing E. Chen United States	28	2.3k 1.8×	419 0.4×	992 1.1×	270 0.4×	411 0.8×	40	3.6k
Iván P. Uray United States	20	1.3k 1.0×	475 0.5×	404 0.5×	434 0.6×	160 0.3×	40	2.3k
Didier Heudes France	36	851 0.7×	1.5k 1.6×	482 0.6×	701 1.0×	873 1.7×	83	4.2k
Marie‐Luise Brennan United States	17	758 0.6×	562 0.6×	837 1.0×	259 0.4×	1.5k 2.9×	28	3.4k
Tuva B. Dahl Norway	23	680 0.5×	308 0.3×	448 0.5×	235 0.3×	501 1.0×	67	2.1k

Countries citing papers authored by Stuart Gallagher

Since Specialization

Citations

This map shows the geographic impact of Stuart Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Gallagher more than expected).

Fields of papers citing papers by Stuart Gallagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Gallagher. The network helps show where Stuart Gallagher may publish in the future.

Co-authorship network of co-authors of Stuart Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Gallagher. A scholar is included among the top collaborators of Stuart Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Gallagher. Stuart Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tseng, Hsin‐Yi, Sara Alavi, Stuart Gallagher, et al.. (2024). BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti‐CTLA‐4 treatment. Pigment Cell & Melanoma Research. 37(6). 744–751. 2 indexed citations

Gallagher, Stuart, et al.. (2023). Creating hope in dystopia: Utopia as Method as social pedagogy in early childhood studies. SHILAP Revista de lepidopterología. 12(1). 2 indexed citations

Emran, Abdullah Al, Hsin‐Yi Tseng, Dilini Gunatilake, et al.. (2021). A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma. Journal of Investigative Dermatology. 141(9). 2238–2249.e12. 10 indexed citations

Ahmed, Farzana, Hsin‐Yi Tseng, Antonio Ahn, et al.. (2021). Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma. Journal of Investigative Dermatology. 142(5). 1444–1455.e10. 16 indexed citations

Emran, Abdullah Al, Stuart Gallagher, Jessamy Tiffen, & Peter Hersey. (2021). Sex bias of females in survival from cancer and infections. Is X the answer?. British Journal of Cancer. 124(7). 1184–1186. 4 indexed citations

Gallagher, Stuart, Robert V. Rawson, Annabelle Mahar, et al.. (2021). Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis. Pathology. 53(7). 830–835. 7 indexed citations

Tiffen, Jessamy, Stuart Gallagher, Fabian V. Filipp, et al.. (2020). EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma. Journal of Investigative Dermatology. 140(12). 2442–2454.e5. 49 indexed citations

Emran, Abdullah Al, Jérémie Nsengimana, Ulf Schmitz, et al.. (2020). Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts. Cancers. 12(8). 2082–2082. 14 indexed citations

Tseng, Hsin‐Yi, Abdullah Al Emran, Dilini Gunatilake, et al.. (2020). Co‐targeting bromodomain and extra‐terminal proteins and MCL1 induces synergistic cell death in melanoma. International Journal of Cancer. 147(8). 2176–2189. 20 indexed citations

10.

Hersey, Peter, Jessamy Tiffen, & Stuart Gallagher. (2019). Shedding light on dabrafenib-induced fevers in patients with melanoma. The Lancet Oncology. 20(12). 1637–1638. 2 indexed citations

11.

Tiffen, Jessamy, Stephen Wilson, Stuart Gallagher, Peter Hersey, & Fabian V. Filipp. (2016). Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma. Neoplasia. 18(2). 121–132. 38 indexed citations

12.

Gowrishankar, Kavitha, Dilini Gunatilake, Stuart Gallagher, et al.. (2015). Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB. PLoS ONE. 10(4). e0123410–e0123410. 191 indexed citations

13.

Hersey, Peter & Stuart Gallagher. (2013). Intralesional immunotherapy for melanoma. Journal of Surgical Oncology. 109(4). 320–326. 41 indexed citations

14.

Gallagher, Stuart, Florian Rambow, Mayuko Y. Kumasaka, et al.. (2012). Beta-catenin inhibits melanocyte migration but induces melanoma metastasis. Oncogene. 32(17). 2230–2238. 84 indexed citations

15.

Trumpp, Andreas, et al.. (2011). Role of myc in melanoma. Pigment Cell & Melanoma Research. 24(4). 861–861. 1 indexed citations

16.

Gallagher, Stuart, Flavie Luciani, Florian Rambow, et al.. (2011). General strategy to analyse melanoma in mice. Pigment Cell & Melanoma Research. 24(5). 987–988. 8 indexed citations

17.

Irvine, Mal, Stuart Gallagher, Carina Fung, et al.. (2010). Amino terminal hydrophobic import signals target the p14ARF tumor suppressor to the mitochondria. Cell Cycle. 9(4). 829–839. 13 indexed citations

18.

Gallagher, Stuart, John F. Thompson, James O. Indsto, et al.. (2008). p16INK4a Expression and Absence of Activated B-RAF Are Independent Predictors of Chemosensitivity in Melanoma Tumors. Neoplasia. 10(11). 1231–1239. 34 indexed citations

19.

Gallagher, Stuart, Richard Kefford, & Helen Rizos. (2005). Enforced Expression of p14ARF Induces p53-Dependent Cell Cycle Arrest but Not Apoptosis. Cell Cycle. 4(3). 465–472. 26 indexed citations

20.

Creager, Mark A., John P. Cooke, M E Mendelsohn, et al.. (1990). Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.. Journal of Clinical Investigation. 86(1). 228–234. 849 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact